See the DrugPatentWatch profile for Kalbitor
What is Kalbitor (ecallantide) used for?
Kalbitor is the brand name for ecallantide, a medicine used to treat acute attacks of hereditary angioedema (HAE) in adults and children 12 years and older. It helps control swelling by inhibiting plasma kallikrein, which is part of the pathway that drives excess bradykinin production during HAE attacks. [1]
How does Kalbitor work in hereditary angioedema?
In HAE, attacks involve increased bradykinin activity, which leads to swelling. Kalbitor blocks plasma kallikrein, reducing bradykinin generation and helping shorten or control an acute attack. [1]
How is Kalbitor given?
Kalbitor is administered by healthcare professionals (it is not a self-administered at-home treatment). The label guidance emphasizes that it must be given in a setting prepared to manage reactions, including anaphylaxis. [1]
What safety issues and warnings are associated with Kalbitor?
Kalbitor has a serious warning for potential hypersensitivity reactions, including anaphylaxis. Because of this risk, it requires administration with appropriate medical monitoring and readiness to treat severe allergic reactions. [1]
What are common questions patients ask before using Kalbitor?
People considering Kalbitor often look for answers about:
- Whether it’s for confirmed HAE attacks (it is used for acute attacks of hereditary angioedema)
- Age eligibility (adult and pediatric patients age 12 and older)
- Allergy and anaphylaxis risk (it carries a serious hypersensitivity/anaphylaxis warning)
- Whether it can be taken at home (it is administered by a healthcare professional in an appropriate clinical setting) [1]
How does Kalbitor compare with other HAE treatments?
Kalbitor is one option for acute HAE attacks that works by blocking plasma kallikrein. Other acute therapies for HAE work through different mechanisms (for example, replacing missing inhibitors or blocking bradykinin activity), so choice depends on availability, patient factors, and prescriber guidance. [1]
Where does Kalbitor fit: acute attack treatment vs long-term prevention?
Kalbitor is used to treat acute HAE attacks. It is not described as a long-term preventive therapy in the basic labeled indication. Long-term prevention uses different approaches and medicines than acute attack control. [1]
Sources
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/